Shanghai - Delayed Quote CNY
DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)
17.46
+0.06
+(0.34%)
At close: 3:00:01 PM GMT+8
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| Chen (Hong) Other Executive | Sale | Aug 16, 2023 | 203,128 |
| Ke (Guoqiang) General Manager | Acquisition | Dec 12, 2023 | 279,568 |
| Liang (Runshi) Secretary | Acquisition | Dec 12, 2023 | 53,200 |
| Peng (Guangzhi) Chief Financial Officer | Acquisition | Dec 12, 2023 | 157,744 |
Related Tickers
1OT.F Ovid Therapeutics Inc.
0.2260
+15.31%
RXK3.F SELLAS Life Sciences Group, Inc.
1.1500
-2.21%
1VT.MU Viking Therapeutics Inc
22.84
+2.10%
EXOZ eXoZymes, Inc.
12.12
-10.42%
AVBP ArriVent BioPharma, Inc.
20.49
-2.80%
RAPP Rapport Therapeutics, Inc.
10.89
-4.31%
MBX MBX Biosciences, Inc.
9.19
+2.17%
DSGN Design Therapeutics, Inc.
4.0800
+0.25%
SEPN Septerna, Inc.
6.32
+2.97%
ACXP Acurx Pharmaceuticals, Inc.
0.4019
+3.87%